Chembio Diagnostics to Report First Quarter 2020 Financial Results on May 4, 2020
27 avr. 2020 16h05 HE
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., April 27, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will...
Chembio Diagnostics Receives Emergency Use Authorization for DPP COVID-19 System for IgG and IgM Antibodies
15 avr. 2020 09h26 HE
|
Chembio Diagnostics, Inc.
First Shipments of the COVID-19 Serological Test have been Released HAUPPAUGE, N.Y., April 15, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care...
Chembio Diagnostics and Stony Brook Medicine Collaborate to Identify Coronavirus Survivors
09 avr. 2020 16h05 HE
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., April 09, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced its DPP...
Chembio Receives Second UNICEF Order for $1.5 Million
08 avr. 2020 08h00 HE
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., April 08, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced a...
Chembio Announces Launch of DPP COVID-19 Serological Point-of-Care Test
31 mars 2020 21h10 HE
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., March 31, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the U.S....
Chembio Diagnostics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
20 mars 2020 08h30 HE
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., March 20, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today reported that, in...
Chembio Diagnostics Receives $4 Million Purchase Order from Bio-Manguinhos for Production of DPP COVID-19 IgM/IgG System in Brazil
20 mars 2020 08h00 HE
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., March 20, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced its receipt...
Chembio Diagnostics Appoints Richard Eberly As Chief Executive Officer
12 mars 2020 16h46 HE
|
Chembio Diagnostics, Inc.
HAUPPAGE, N.Y., March 12, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the...
Chembio Diagnostics Reports Fourth Quarter and Full Year 2019 Financial Results
12 mars 2020 16h07 HE
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., March 12, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial...
Chembio and LumiraDx Announce COVID-19 Strategic Partnership
12 mars 2020 08h00 HE
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., March 12, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced that it has...